CEMQ:F:F-iShares Edge MSCIope Quality Factor UCITS (EUR)

ETF | Others |

Last Closing

USD 10.378

Change

+0.24 (+2.37)%

Market Cap

USD 0.47B

Volume

148.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.21 (-0.75%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.29 (-0.57%)

USD 114.13B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.26 (-0.21%)

USD 106.46B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.30 (-0.52%)

USD 100.12B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.09 (-0.55%)

USD 63.18B
VUAA:F Vanguard S&P 500 UCITS Acc

+1.87 (+1.73%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.15 (-0.06%)

USD 51.11B
XJSE:F Xtrackers II - Japan Governmen..

+0.07 (+0.87%)

USD 43.12B
0ZC:F Zscaler Inc

+5.56 (+3.12%)

USD 37.92B

ETFs Containing CEMQ:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.69% 73% C 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.69% 73% C 62% D
Trailing 12 Months  
Capital Gain 9.01% 48% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.01% 43% F 46% F
Trailing 5 Years  
Capital Gain 35.70% 66% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.70% 65% D 49% F
Average Annual (5 Year Horizon)  
Capital Gain 11.21% 72% C 67% D+
Dividend Return 11.21% 70% C- 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.26% 51% F 83% B
Risk Adjusted Return 84.55% 84% B 88% B+
Market Capitalization 0.47B 61% D- 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike